Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 1998, p. 1278-1280, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Triazine Dye, Cibacron Blue F3GA, Decreases Oxacillin
Resistance Levels in Methicillin-Resistant Staphylococcus
aureus
Chiharu
Shirai,1,2
Motoyuki
Sugai,2,*
Hitoshi
Komatsuzawa,2
Kouji
Ohta,2
Michio
Yamakido,1 and
Hidekazu
Suginaka2
Department of Internal Medicine II, Hiroshima
University School of Medicine,1 and
Department of Microbiology, Hiroshima University School of
Dentistry,2 Hiroshima 734, Japan
Received 20 October 1997/Returned for modification 8 January
1998/Accepted 10 February 1998
 |
ABSTRACT |
Cibacron blue F3GA (CB) was found to reduce the MIC of oxacillin
for methicillin-resistant Staphylococcus aureus (MRSA).
This effect was not observed with methicillin-susceptible S. aureus. CB alters the resistance level of MRSA through a
factor(s) other than mecA-related products, major
autolysins, or femAB products. The exact target(s) of CB in
causing the effect is unknown.
 |
TEXT |
Cibacron blue F3GA (CB) is a
triazinyl dye widely used as the affinity ligand for dye-ligand
chromatography. CB is structurally similar to naturally occurring
heterocycles, such as nucleoside phosphate, NAD+, coenzyme
A, and folic acid (1-3, 8). It has been demonstrated that
CB specifically binds to nucleotide binding sites of kinases and
dehydrogenases and that some of the enzyme activities are inhibited by
CB (1, 4, 6, 7). The aim of this study was to
investigate the effect of CB on the in vitro susceptibility of
methicillin-resistant Staphylococcus aureus
(MRSA) to oxacillin. CB used in this study was from Sigma
Chemical Co., St. Louis, Mo. (C 9534) and was formerly called reactive
blue 2 (R 4502); it has an A-ring orthosulfonic acid
(9). CB purified by reversed-phase high-pressure liquid
chromatography according to the procedure described by Hanggi and
Carr (9) behaved similarly to unpurified CB, and
consequently CB was used without purification in this study. MICs were
determined by a microdilution method (13), and population
analysis was carried out as described elsewhere (12). CB
alone was not inhibitory to staphylococcal strains when used at up to
2,500 µg/ml in the experiments. The effect of CB on in vitro
susceptibility to oxacillin was evaluated with 28 MRSA and 10 methicillin-susceptible S. aureus (MSSA) strains. For all
MRSA strains, the MIC of oxacillin was significantly reduced in the
presence of CB concentrations of 39 µg/ml or higher (Fig. 1). Highly
resistant MRSA strains appeared to be less susceptible to the
sensitizing effect of CB, but 78 to 156 µg of CB per ml markedly
reduced the MICs of oxacillin for those strains. We therefore employed
100 µg of CB per ml in further studies, unless otherwise noted. On
the other hand, MICs of oxacillin for MSSA did not change at all in the
presence of CB (data not shown). A population analysis of 28 MRSA
strains and 2 MSSA strains was carried out in the presence and absence
of CB. In most cases, the population curve of homogeneously or
heterogeneously oxacillin-resistant MRSA shifted to the left in the
presence of CB. On the other hand, population curves of MSSA did not
change at all in the presence of CB and confirmed the results of MIC
analysis. CB alone also had no effect on the population curve. This
sensitizing effect of CB was observed only when
-lactam was used
with CB (Table 1). Various triazinyl dyes related to CB were tested for an effect on the sensitivity of MRSA to
oxacillin and were found to have a very weak effect on a limited number
of strains (data not shown).

View larger version (87K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of CB on the susceptibilities of MRSA isolates to
oxacillin. The column height indicates the MIC of
oxacillin.
|
|
We further assessed the effect of CB on the bactericidal activity of
oxacillin with S. aureus MR15. When CB was added to
exponentially growing MR15, the cells grew in clusters as described
previously (20). Measurement of CFU of the culture after
brief sonication to disperse clusters revealed that CB did not affect
the growth of MR15. Oxacillin at a concentration of 16 µg/ml also did
not significantly affect the growth of strain MR15. On the other hand, coincubation of CB with oxacillin (16 µg/ml) completely inhibited growth but did not reduce the number of CFU. These results suggest that
the sensitization effect of CB on MRSA cells is bacteriostatic.
We studied the effect of CB on the synthesis of penicillin-binding
proteins (PBPs) in strain MR6-2 (
-lactamase free) (13). S. aureus cell membranes were prepared from cells grown in
the presence or absence of CB. The binding of
-lactam antibiotics to
PBPs was investigated with 14C-labeled benzylpenicillin (10 to 30 Ci/mmol) (Amersham International, Bucks, United Kingdom)
(5). The amounts of PBP2' and PBP2 were not affected by the
presence of CB in the culture. Next, the effect of CB on the binding of
14C-labeled benzylpenicillin to PBPs was investigated. The
binding study revealed that the kinetics also were not affected by CB.
CB has been shown to inhibit bacteriolytic enzyme activities of
S. aureus (16, 19). To determine whether
bacteriolytic enzymes are involved in the sensitizing effect of CB, we
studied the effect of CB on the resistance levels of Lyt
mutants, which virtually lack major autolysins of S. aureus
(the atl gene products), and of their parent, MRSA MR6
(13). Population analysis of two Lyt
mutants,
Lyt-2 and Lyt-5, derived from MR6 indicated that the Lyt
phenotype had no effect on the levels of resistance of these strains to
oxacillin. Moreover, the mutants were as sensitive as the parent
strains to the effect of CB on susceptibility to oxacillin. The
mecI-mecR element and penicillinase plasmids were shown to
affect the resistance level of MRSA (11, 14, 22). We studied
the effect of CB on the resistance level of a prototype MRSA strain,
N315, and its isogenic derivatives N315P (penicillinase negative)
and N315-IR74 (mecI
mecR::tet) (14). The
population curve was shifted to the left irrespective of the status of
the mecI-mecR element and the penicillinase plasmid. We
studied whether CB could affect the structure of peptidoglycan as
previously observed in studies demonstrating the lower sensitivity of
femAB mutants to lysostaphin compared to that of the wild
type (10, 15). We determined the susceptibilities of several
MRSA strains grown in the presence or absence of CB to various
bacteriolytic enzymes with different bond specificities, including
62-kDa N-acetylmuramyl-L-alanine amidase
(18), 51-kDa endo-
-N-acetylglucosaminidase
(17), and lysostaphin, by zymography (12).
Regardless of whether the cells were grown in the presence or absence
of CB, the minimum bacteriolytic doses of
N-acetylmuramyl-L-alanine amidase,
N-acetylglucosaminidase, and lysostaphin for the strains
were identical.
In conclusion, our results suggested that CB alters the resistance
level of MRSA through a factor(s) other than
mecA-related products, major autolysins, or
femAB products. Although the exact target(s) of CB in
causing this sensitizing effect is not clear, it is likely that the
target is involved in a critical metabolic pathway, given that PBP2' is
the only functional PBP. Further studies of the sensitization effect of
CB may help to elucidate the molecular mechanism of methicillin
resistance in S. aureus.
 |
ACKNOWLEDGMENTS |
We thank Keiichi Hiramatsu, Juntendo University, for bacterial
strains. We also thank Tadashi Oshida, Tanabe Seiyaku Co., Ltd., for
helpful discussions and Masao Kuwabara, Hiroshima Prefectural Hospital,
for encouragement.
This investigation was supported in part by a grant from the Scientific
Research Funds (07557115 and 084557481) of the Ministry of Education,
Science and Culture, Japan (1996 and 1997).
 |
FOOTNOTES |
*
Corresponding author. Mailing address:
Department of Microbiology, Hiroshima University School of Dentistry,
Kasumi 1-2-3, Minami-ku, Hiroshima City, Hiroshima 734-8553, Japan.
Phone: 81-82-257-5637. Fax: 81-82-257-5639. E-mail:
sugai{at}ipc.hiroshima-u.ac.jp.
 |
REFERENCES |
| 1.
|
Ashton, A. R., and G. M. Polya.
1978.
The specific interaction of cibacron and related dyes with cyclic nucleotide phosphodiesterase and lactate dehydrogenase.
Biochem. J.
175:501-506[Medline].
|
| 2.
|
Baird, J. K.,
R. F. Sherwood,
R. J. G. Carr, and A. Atkinson.
1976.
Enzyme purification by substrate elution chromatography from procion dye-polysaccharide matrices.
FEBS Lett.
70:61-66[Medline].
|
| 3.
|
Beissner, R. S., and F. B. Rudolph.
1978.
Interaction of cibacron blue 3G-A and related dyes with nucleotide-requiring enzymes.
Arch. Biochem. Biophys.
189:76-80[Medline].
|
| 4.
|
Biellmann, J.-F.,
J.-P. Samama,
C. I. Bränden, and H. Eklund.
1979.
X-ray studies of the binding of cibacron blue F3GA to liver alcohol dehydrogenase.
Eur. J. Biochem.
102:107-110[Medline].
|
| 5.
|
Brown, D. F., and P. E. Reynolds.
1980.
Intrinsic resistance to -lactam antibiotics in Staphylococcus aureus.
FEBS Lett.
122:275-278[Medline].
|
| 6.
|
Clonis, Y. D.,
M. J. Goldfinch, and C. R. Lowe.
1981.
The interaction of yeast hexokinase with procion green H-4G.
Biochem. J.
197:203-211[Medline].
|
| 7.
|
Clonis, Y. D., and C. R. Lowe.
1980.
Triazine dyes, a new class of affinity labels for nucleotide-dependent enzymes.
Biochem. J.
191:247-251[Medline].
|
| 8.
|
Edwards, R. A., and R. W. Woody.
1979.
Spectroscopic studies of cibacron blue and congo red bound to dehydrogenases and kinases, evaluation of dyes as probes of the dinucleotide fold.
Biochemistry
18:5197-5204[Medline].
|
| 9.
|
Hanggi, D., and P. Carr.
1985.
Analytical evaluation of the purity of commercial preparations of cibacron blue F3GA and related dyes.
Anal. Biochem.
149:91-104[Medline].
|
| 10.
|
Henze, U.,
T. Sidow,
J. Wecke,
H. Labischinski, and B. Berger-Bächi.
1993.
Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus.
J. Bacteriol.
175:1612-1620[Abstract/Free Full Text].
|
| 11.
|
Hiramatsu, K.,
E. Suzuki,
H. Takayama,
Y. Katayama, and T. Yokota.
1990.
Role of penicillinase plasmids in the stability of the mecA gene in methicillin-resistant Staphylococcus aureus.
Antimicrob. Agents Chemother.
34:600-604[Abstract/Free Full Text].
|
| 12.
|
Komatsuzawa, H.,
M. Sugai,
C. Shirai,
J. Suzuki,
K. Hiramatsu, and H. Suginaka.
1995.
Triton X-100 alters the resistance level of methicillin-resistant Staphylococcus aureus to oxacillin.
FEMS Microbiol. Lett.
134:209-212[Medline].
|
| 13.
|
Komatsuzawa, H.,
J. Suzuki,
M. Sugai,
Y. Miyake, and H. Suginaka.
1994.
The effect of Triton X-100 on the in-vitro susceptibility of methicillin-resistant Staphylococcus aureus to oxacillin.
J. Antimicrob. Chemother.
34:885-897[Abstract/Free Full Text].
|
| 14.
|
Kuwahara-Arai, K.,
N. Kondo,
S. Hori,
E. Tateda-Suzuki, and K. Hiramatsu.
1996.
Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2' production.
Antimicrob. Agents Chemother.
40:2680-2685[Abstract].
|
| 15.
|
Maidhof, H.,
B. Reinicke,
P. Blümel,
B. Berger-Bächi, and H. Labischinski.
1991.
femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
J. Bacteriol.
173:3507-3513[Abstract/Free Full Text].
|
| 16.
|
Sugai, M.,
T. Akiyama,
H. Komatsuzawa,
Y. Miyake, and H. Suginaka.
1990.
Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis.
J. Bacteriol.
172:6494-6498[Abstract/Free Full Text].
|
| 17.
|
Sugai, M.,
H. Koike,
Y.-M. Hong,
Y. Miyake,
R. Nogami, and H. Suginaka.
1989.
Purification of a 51 kDa endo- -N-acetylglucosaminidase from Staphylococcus aureus.
FEMS Microbiol. Lett.
61:267-272.
|
| 18.
|
Sugai, M.,
H. Komatsuzawa,
T. Akiyama,
Y.-M. Hong,
T. Oshida,
Y. Miyake,
T. Yamaguchi, and H. Suginaka.
1995.
Identification of endo- -N-acetylglucosaminidase and N-acetylmuramyl-L-alanine amidase as cluster-dispersing enzymes in Staphylococcus aureus.
J. Bacteriol.
177:1491-1496[Abstract/Free Full Text].
|
| 19.
|
Sugai, M.,
K. Ooku,
T. Akiyama,
S. Inoue,
S. Iseda,
Y. Miyake, and H. Suginaka.
1991.
Suppression of penicillin-induced lysis of Staphylococcus aureus by cibacron blue 3G-A.
FEMS Microbiol. Lett.
80:151-154.
|
| 20.
|
Sugai, M.,
K. Ooku,
T. Takata,
Y. Miyake, and H. Suginaka.
1990.
A triazine dye, cibacron blue 3G-A induces Staphylococcus aureus to form giant clusters.
FEMS Microbiol. Lett.
67:175-178.
|
| 21.
|
Suzuki, E.,
K. Kuwahara-Arai,
J. F. Richardson, and K. Hiramatsu.
1993.
Distribution of mec regulator genes in methicillin-resistant Staphylococcus clinical strains.
Antimicrob. Agents Chemother.
37:1219-1226[Abstract/Free Full Text].
|
| 22.
|
Tesch, W.,
C. Ryffel,
A. Strässle,
F. H. Kayser, and B. Berger-Bächi.
1990.
Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2'.
Antimicrob. Agents Chemother.
34:1703-1706[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, May 1998, p. 1278-1280, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Stapleton, P. D., Shah, S., Ehlert, K., Hara, Y., Taylor, P. W.
(2007). The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. Microbiology
153: 2093-2103
[Abstract]
[Full Text]
-
Shibata, H., Kondo, K., Katsuyama, R., Kawazoe, K., Sato, Y., Murakami, K., Takaishi, Y., Arakaki, N., Higuti, T.
(2005). Alkyl Gallates, Intensifiers of {beta}-Lactam Susceptibility in Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
49: 549-555
[Abstract]
[Full Text]
-
Shimizu, M., Shiota, S., Mizushima, T., Ito, H., Hatano, T., Yoshida, T., Tsuchiya, T.
(2001). Marked Potentiation of Activity of beta -Lactams against Methicillin-Resistant Staphylococcus aureus by Corilagin. Antimicrob. Agents Chemother.
45: 3198-3201
[Abstract]
[Full Text]
-
Hamilton-Miller, J. M. T., Shah, S.
(2000). Activity of the tea component epicatechin gallate and analogues against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother
46: 852-853
[Full Text]